Paxman

Paxman’s scalp cooling technology helps prevent hair loss during cancer treatment.

Clinical guidelines recommend scalp cooling to reduce chemotherapy-related hair loss and improve patient outcomes.

Essential patient information for preventing chemotherapy side effects including patient guidance, what to expect, and FAQs.

Paxman’s technology aims to reduce chemotherapy-induced peripheral neuropathy.

Scalp cooling during chemotherapy can retain hair and promote faster, healthier regrowth in patients who experience hair loss.

Kimberly James LaBrier retained part of her hair during stage 1 invasive ductal breast cancer treatment with Taxotere and Cytoxan using scalp cooling.

Lauren McClain, a Pittsburgh schoolteacher and mother of three, wrote *Mom’s Magical Crown*, a children’s book explaining chemotherapy and scalp cooling.

Paxman recently attended the Oncology Nursing Society 2025 Congress in Denver, CO, to talk with oncology professionals, about scalp cooling and chemotherapy side effect management, and to discover the latest research data. This year marked the 50th anniversary of the congress, making it a special and unforgettable experience. Meeting passionate nurses from across the US […]

The Centre François Baclesse in Caen is comparing efficacy between manual gel caps and the Paxman Scalp Cooling System in the ICELAND Study.

Paxman develops clinically-proven cryotherapy solutions to help cancer patients prevent hair loss and peripheral neuropathy during chemotherapy treatment.

California now mandates insurance coverage for FDA-cleared scalp cooling during chemotherapy, following the passage of **Assembly Bill 1682**. The law, signed by Governor **Gavin Newsom**, ensures cancer patients access to this treatment option. Paxman Group advocates for expanded patient access to scalp cooling solutions.

Sep 2026Paxman GroupNews article

Paxman Group highlights how family support plays a critical role in a patient’s scalp cooling experience during cancer treatment. Patients often focus on practical concerns like hair retention and wig use, but emotional backing from loved ones helps navigate the challenges. The company emphasizes that a strong support system can ease the psychological burden of scalp cooling for individuals undergoing treatment.

Sep 2026Paxman GroupNews article

Paxman’s Research and Development Team secures funding approval from Innovate UK for a new project. The UK-based innovation agency supports the initiative following a successful presentation by Paxman. The funding will advance their development efforts in an unspecified but 'exciting' new area.

Sep 2026Paxman GroupNews article

The Extremadura Regional Government funds nine Paxman Scalp Cooling Systems for public hospitals under El Servicio Extremeño de Salud (SES). These devices help reduce chemotherapy-induced hair loss for cancer patients. The initiative expands access to supportive care across Extremadura’s hospital network.

Jul 2026Paxman GroupNews article